Pure Global
NCT05099588

The Incidence of Treatment-requiring Retinopathy of Prematurity in Greece

The Incidence of Treatment-requiring Retinopathy of Prematurity in Greece: a Multicenter Prospective Cohort Study
Aristotle University Of Thessaloniki·ClinicalTrials.gov·otherCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Retinopathy of Prematurity
Drug/Device/Intervention
Other: observational study
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
Aristotle University Of Thessaloniki
Location
Thessaloníki, Greece
Timeline & enrollment
Phase
N/A
Start date
Jun 01, 2020
End date
Jan 15, 2023
Enrollment
43 participants
Primary outcome

The incidence of treatment-requiring ROP (TR-ROP) in Greece

Summary

A prospective observational study of the incidence of treatment-requiring ROP (TR-ROP), at a
 national level, in Greece.

ICD-10 classifications
Retinopathy of prematurityOther proliferative retinopathyBackground retinopathy and retinal vascular changesDiabetic retinopathyRetinal disorder, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05099588
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05099588 through Pure Global AI's free database. This phase not specified trial is sponsored by Aristotle University Of Thessaloniki and is currently Completed. The study focuses on Retinopathy of Prematurity. Target enrollment is 43 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.